SK

Steven Kazmirski

AA Astrazeneca Ab: 4 patents #334 of 1,971Top 20%
FT Fulcrum Therapeutics: 3 patents #9 of 17Top 55%
Overall (All Time): #698,676 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
12109198 Macrocyclic azolopyridine derivatives as EED and PRC2 modulators Ivan Viktorovich Efremov, Qingyi Li, Lorin A. Thompson, III, Owen Brendan Wallace, Shawn Johnstone +2 more 2024-10-08
11590111 Macrocyclic azolopyridine derivatives as EED and PRC2 modulators Ivan Viktorovich Efremov, Qingyi Li, Lorin A. Thompson, III, Owen Brendan Wallace, Shawn Johnstone +2 more 2023-02-28
11472816 Mcl-1 inhibitors and methods of use thereof Alexander Hird, Matthew BELMONTE, Wenzhan Yang, Paul SECRIST, Daniel W. ROBBINS +6 more 2022-10-18
10973805 Macrocyclic azolopyridine derivatives as EED and PRC2 modulators Ivan Viktorovich Efremov, Qingyi Li, Lorin A. Thompson, III, Owen Brendan Wallace, Shawn Johnstone +2 more 2021-04-13
10889594 MCL-1 inhibitors and methods of use thereof Alexander Hird, Wenzhan Yang, Daniel W. ROBBINS, Dedong Wu, Bo Peng +4 more 2021-01-12
10196404 MCL-1 inhibitors and methods of use thereof Alexander Hird, Matthew BELMONTE, Wenzhan Yang, Paul SECRIST, Daniel W. ROBBINS +6 more 2019-02-05
9840518 MCL-1 inhibitors and methods of use thereof Alexander Hird, Wenzhan Yang, Daniel W. ROBBINS, Dedong Wu, Bo Peng +2 more 2017-12-12